About us

The next generation sequencing (NGS) era has seen a reduction of sequencing costs by orders of magnitude; this in combination with the consistent development of the technologies to selectively capture sequences, has allowed for high throughput sequencing of large and specific genomic regions.

The ThromboGenomics platform is a single and affordable DNA-based test for 74 genes involved in 79 coagulation, platelet and thrombotic disorders. As well as simultaneously screening multiple genes, the ThromboGenomics platform test will scan most of the possible mutations in those regions, from just a single blood sample.